Sunday, July 19, 2020
9:00 a.m. – 10:00 a.m. EDT
4:00 p.m. – 5:00 p.m. Israel Time
Register here

Join Mayer Brown and PwC for a webinar on Life Sciences IPOs.  Panelists will discuss the pre-IPO and IPO markets and IPO preparedness, among other topics. CEO and Co-Founder of InMode, Moshe Mizrahy, will join our

On June 23, 2020, the Division of Corporation Finance (Division) of the US Securities and Exchange Commission (SEC) issued CF Disclosure Guidance: Topic No. 9A (CF 9A), providing guidance on operations, liquidity, and capital resources disclosures that companies should consider with respect to COVID-19-related disruptions. On that same date, the SEC’s Office of the Chief

In addition to a host of significant general business concerns, such as those relating to liquidity and financing opportunities, revenues, supply chain and employee and community health and welfare, the novel coronavirus known as COVID-19 has raised a number of issues specific to public companies that file reports with the US Securities and Exchange Commission.

In this article published in The Review of Securities & Commodities Regulation, we discuss the implications of the SEC’s recent actions to modernize and simplify disclosure requirements applicable to foreign private issuers (“FPIs”).

See full article here.